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EVIEWS have already demonstrated very acceptable results from the retrosigmoid surgical removal of the acoustic neurinoma. ~.6-8.~3, E7 The results of other surgical approaches ~~ and radiosurgery 3 have also been detailed recently. Decreasing surgical morbidity, including improved facial and cochlear preservation, would be expected as subspecialization, routine cranial nerve monitoring, and the muitidisciplinary team approach become more commonly practiced.
To determine the advantages and disadvantages of various treatment modalities, it is necessary to review the results of these techniques periodically. Various surgical approaches, stereotactic radiosurgery, and radical intracapsular removal have all been suggested as treatment options) '3'6'13 '16'22'27 Older or debilitated patients having small tumors can be followed with periodic imaging studies. 29 The appropriate management strategy for the individual patient can best be selected when the risks and limitations, as well as the benefits, of various treatment choices are clearly understood.
The purpose of this communication is to define the current status of retrosigmoid removal of acoustic neurinomas.
Clinical Material and Methods

Patient Population
We reviewed a series of 255 consecutive patients who underwent surgery (256 procedures) between January, 1984, and December, 1990. We selected January, 1984, as the starting point because at that date cranial nerve monitoring became routine and was used on nearly all patients undergoing acoustic tumor removal at our institution. Also, by 1984, a team approach involving both a neurosurgeon and an otologist was routinely utilized. During the evolution of acoustic neurinoma surgery, subspecialization had limited the number of otolaryngologists and neurosurgeons involved with this surgery at the Mayo Clinic.
The 255 patients in this series included 126 men and 0 3 * The pure tone average was found to be impaired in all 221 patients who had hearing before surgery. In the 52 patients who had residual hearing following surgery, there was often a reduction in the pure tone average; however, three patients did have a pure tone average of 91 dB postoperatively, which was better than that noted in the preoperative group. 129 women. The age range was 16 to 84 years (mean 50 years). Of these, 221 patients were found by preoperative audiometric testing to have hearing present. The preoperative hearing acuity of the 52 patients with postoperative hearing preservation is further delineated in Tables 1 and 2 . The size of the 256 tumors, determined by measuring the maximum tumor dimension, varied from an intracanalicular tumor to a single 6.5-cm tumor. A breakdown of tumor size in relation to facial nerve function is depicted in Fig. 1 .
Surgical Technique
The retrosigmoid approach provides satisfactory visualization of the acoustic tumor and especially of the vasculature and neural elements. The drawings in 90-100  15  6  80-89  7  2  70-79  5  7  60-69  5  2  50-59  2  1  40-49  5  6  30-39  3  1  20-29  1  3  10-19 2 3 0-9 8 21 * Speech discrimination was often further impaired following removal of the acoustic neurinoma. Of the 221 patients who had preoperative hearing, 52 continued to have hearing after surgery although in approximately one-half of these speech discrimination was very poor.
2 illustrate the surgical technique used. For tumors less than 2 cm in size, it is now our usual practice to place the patient in the supine position with the head rotated toward the opposite side. The head is elevated slightly above the level of the heart to decrease the venous bleeding as well as to provide some additional relaxation of the posterior fossa. The dura is opened as cerebrospinal fluid (CSF) is drained through a previously placed lumbar malleable needle. When approximately 20 to 40 cc of CSF has been drained, the tumor can usually be identified. The lower cranial nerves are then identified and carefully separated from the tumor and held slightly away with small cottonoid patties. The draining of the CSF makes it possible to remove the tumor without the use of a retractor.
Early in the dissection it is important to identify the thin veil of arachnoid that often covers the surface of the tumor. This is peeled away. Most of the vessels that can be identified on the surface can then be carefully peeled from the tumor; the preservation of these vessels is considered to be important since they may often be vital to the maintenance of cochlear function. Occasionally, the cochlear response can be lost as we are peeling these vessels from the surface of the tumor. The monitored cochlear response can also be lost if it becomes necessary to coagulate some of these vessels. It has become our practice to follow this plane between the tumor and the cerebellum back to the brain stem and, when possible, even to the proximal seventh cranial nerve before debulking the tumor.
As we start to debulk, a small amount of bleeding from within the tumor often makes it somewhat more difficult to identify the plane between the tumor and the brain stem. Therefore, we prefer to find this plane first. Once we have identified the proximal seventh nerve, we begin to debulk the tumor and continue to roll the tumor laterally as we do so. Care is taken only to debulk the tumor centrally and to leave the capsule If any facial muscle response is noted, this is helpful in early localization of the facial nerve. This procedure is repeated throughout the operation as the tumor is debulked until we are confident about the location and course of the facial nerve. The inset demonstrates the usual location of the seventh and eighth cranial nerves running medial and then anterior to the tumor. The seventh cranial nerve runs posterior to the tumor about 2% of the time. d: Arteries and veins as well as cerebellum and brain stem are carefully dissected from the tumor and the proximal fifth, seventh, eighth, and lower cranial nerves are identified, e: Once the cranial nerves are identified proximally, the tumor is debulked and is continually rolled laterally, gently dissecting the adherent cranial nerves from the tumor. Often, gentle traction on the tumor with suction or even a microbiopsy punch aids in this dissection, f: After the major portion of the intracranial extent of the tumor has been removed, the internal auditory canal is opened and the seventh and eighth nerves are identified laterally. Again the dissection is continued, this time from lateral to medial. The most attenuated portion of the nerve is usually found to be at the entrance of the seventh and eighth nerves to the internal auditory canal and this most difficult part of the dissection is aided by having both distal and proximal exposures to the seventh and eighth nerves.
of the tumor intact since this capsule is helpful in maintaining the plane of dissection between the seventh nerve and the tumor. Care must also be taken during debulking not to damage the posterior capsule of the tumor; doing so could result in inadvertent brain-stem, vascular, or cranial nerve injury. We prefer to debulk the tumor with suction and a microbiopsy punch. The slightest irritation or movement of the seventh cranial nerve will be detected with the monitoring electrodes, which allows the surgeon to modify the procedure appropriately. Cautery, laser, and the ultrasonic surgical aspirator, when used, should be applied very cautiously in the vicinity of the posterior capsule since these instruments may cause complete nerve transection without any warning firing of the seventh nerve. The more mechanical debulking technique seems more likely to induce nerve firing as the posterior capsule is approached.
With tumors larger than 2 cm in diameter we believe that operating with the patient in the sitting position is advantageous because the brain is somewhat less tense and any bleeding from the tumor or the area around the tumor runs out of the wound rather than pooling in the region where the surgeon is working. This decreases operative time since the surgeon can now use both hands to dissect the tumor from the neural element. It is considered absolutely essential to maintain immaculate hemostasis since any blood in the plane of dissection would not only interfere with one's ability to precisely identify the seventh nerve but might also require additional suction and cause trauma to the brain stem and cranial nerves. By identifying some of this medial tumor plane early, the surgeon has a better idea of the depth of the tumor and can be more aggressive with debulking. Once the medial tumor plane has been identified, often in 10 or 15 minutes, much of the mass can be gutted so that it can be dealt with like a much smaller tumor. After the proximal portion of the seventh nerve is identified, we continue to roll the tumor laterally, debulking it, and placing cottonoid patties medial to the tumor to hold the capsule of remaining tumor away from the brain stem and proximal seventh nerve. As the remaining tumor becomes smaller, it is possible to identify progressively more of the seventh nerve. Placing a small amount of traction on the tumor capsule with the use of a suction or even a small punch forceps often pushes the seventh nerve away from the tumor capsule in a manner that continues the development of the plane between the seventh nerve and the tumor. We have found it more helpful to push the seventh nerve rostrally with a small dissecter rather than to peel the tumor away from the nerve, since in doing the latter it is sometimes possible inadvertently to cut the nerve with the dissecting instrument. Pushing the seventh nerve rostrally and holding or applying gentle traction on the tumor capsule aids in identifying a plane of dissection that can usually be continued to within approximately 5 to 6 mm from the porus acusticus.
With this technique it is possible to reduce even the largest tumor to a much smaller lesion that only extends approximately 5 to 8 mm into the posterior fossa. At this point we believe it is safer to proceed with drilling off the posterior porus, identifying the seventh and eighth nerves laterally, and following them back toward the now already well-defined seventh and eighth nerves medially. We consider that the usual site of greatest difficulty in separating the tumor from the seventh and eighth nerve complex is in the region just next to the medial entrance to the porus. Having already identified the nerve proximally and distally, one is able to visualize better the remaining seventh and eighth nerves. Saving this most difficult part of the dissection until last provides the best chance of preserving both the anatomical and physiological integrity of the seventh and eighth nerves. In those rare cases where the seventh nerve is transected, a primary repair is relatively easy since we have already identified a large amount of proximal seventh nerve and approximately 1 cm of distal seventh nerve.
Following removal of the tumor, proximal and distal stimulation of the seventh nerve provides instant feedback concerning the physiological integrity of the seventh nerve. The seventh nerve is also monitored throughout our dissection, and we can determine at which points we are irritating it and thereby modify our technique to keep this irritation to a minimum. By carefully observing cochlear responses throughout the operation, we can also modify our technique slightly in an effort to increase the likelihood of cochlear preservation. One example of this is the extra effort that is now taken to maintain proximal blood supply to the cochlear nerve and cochlear apparatus. We have found, for example, that some of the tiny vessels that we initially thought went to the tumor, actually run along the tumor to the cochlear apparatus; by maintaining proper tissue planes it is not necessary to sacrifice these vessels but rather they should be separated from the tumor and preserved. Also, knowing where the seventh and eighth nerves are proximally located might modify some of the work that is done within the porus for the more distal tumor removal.
Following the tumor removal, any opened mastoid air cells within the porus are carefully bone-waxed, then further wax containing bone dust is applied. We have essentially given up the practice of placing fat or muscle in the porus since we do not believe that this plays a significant role in lessening the likelihood of a CSF leak. Also, fat or muscle tissue within the porus often enhances on magnetic resonance (MR) imaging or computerized tomography (CT) and this can give confusing information concerning whether or not there is a tumor recurrence. Often the presence of this foreign material is interpreted as possible recurrent or residual tumor, and a radiologist discussing this differential certainly is not reassuring to the patient, the referring doctor, or the surgical team.
Following the meticulous obliteration of the mastoid air cells, the dura is closed in a watertight manner usually using a graft. The mastoid air cells are bonewaxed and the wound is dosed in layers. We have not replaced the removed bone and have not seen any apparent disadvantage from this method.
We recognize that there are many different techniques for removing tumors from this region and do not believe that this is the only way to accomplish it. However, we do believe that the intraoperative monitoring of both facial and cochlear nerve function has improved our learning curve, since we can often recognize immediately when some maneuver or technique results in injury to the seventh or eighth cranial nerve.
Intraoperative Monitoring
Intraoperative facial nerve monitoring was performed in 245 patients, and cochlear nerve monitoring was conducted in 90 in whom cochlear nerve function was adequate to provide obtainable baseline waveforms.* A registered electrodiagnostic technologist supervised by a neurologist with an expertise in intraoperative monitoring was in the operating room to help with potential technical problems and to clarify questions concerning compound muscle action potential measurements and evoked responses.
Patienl Positioning
Although we are presently operating on more patients in the sitting position, 217 of these procedures were performed with the patient in the supine position, the * Viking II nerve monitoring device manufactured by Nicolet Biomedical Instruments, Madison, Wisconsin. head rotated away from the side of the tumor, and the neck slightly flexed so as to elevate the ipsilateral ear approximately 10 cm above the heart. In 38 operations, the patient was sitting and the head was turned toward the side of the tumor. For the small and medium-sized acoustic tumors, a supine position was frequently used; however, for large tumors we have once again started routinely placing patients in the sitting position (Fig. 3) since the venous and posterior fossa pressures are lower in this position. Because intraoperative bleeding does not pool at the site where one is operating but drains from the wound, it is our impression that this position decreases surgical operating time significantly. We have not found any increased morbidity with this position. However, we do not believe that either position in itself has any effect on whether we are able to save the facial nerve or preserve the patient's hearing.
Because both positions involve potential risk for air emboli, a Doppler ultrasound monitor was used on all patients. A tight atrial catheter for air aspiration was always placed when the patient was sitting, but not considered necessary for patients undergoing surgery in the supine position, since intraoperative venous air recognized early can be easily controlled by modifying the operating table position. The Doppler ultrasound monitor not only serves to detect intraoperative venous air but also provides the surgeon with constant auditory monitoring of cardiac rhythm, which can be helpful when working around the brain stem and the fifth and 10th cranial nerves.
All operations were performed using a team approach involving a neurosurgeon and otological surgeon, to ensure removal of both the intracranial tumor and intracanalicular portion of the tumor. Although we now rarely perform preoperative angiography, 24 patients in this series did undergo angiography. All patients received preoperative CT scans and/or MR imaging with gadolinium enhancement.
Results
The mean surgical time of all procedures was 6 hours (range 165 to 999 minutes). The mean operative time of patients with preserved hearing was 4.5 hours with a   FIG. 4 . Pie graph showing postoperative facial nerve function in 161 acoustic neurinoma patients. At follow-up visits 1 year after acoustic neurinoma removal, the breakdown of facial nerve function according to percentage of normal facial function was determined. Groupings are based on the House criteria: 9 1 = 100% function; 1I = 75% to 99%; III = 50% to 74%; IV = 25% to 49%; V = 1% to 24%; and VI = 0%.
range of 175 to 680 minutes, consistent with the latter group having smaller tumors.
Completeness of Tumor Removal
We believed that we were able to accomplish a total tumor removal in 249 of the 256 procedures. In seven patients there was thought to be some tumor left behind. Six of these seven patients had essentially all tumor removed except for some microscopic deposits on the seventh nerve. It was not known whether these remaining apparent deposits were viable tumor or simply a reaction on the seventh nerve secondary to the tumor. The remaining patient with residual tumor was a young woman in her third trimester of pregnancy, and for various reasons the operation was terminated after a generous debulking had been accomplished.
Facial Nerve Function
Anatomically, 237 (92.6%) of the facial nerves in 256 procedures were preserved. It was possible to perform an end-to-end anastomosis on seven of the 19 divided facial nerves and an additional patient had a cable graft inserted. Thus, at the completion of the surgery, it was believed that 245 facial nerves (95.7%) had a chance for spontaneous function.
In the 11 patients in whom the anatomical continuity of the facial nerve was not maintained or re-established, early spinal accessory (seven cases) or hypoglossal-facial (two cases) anastomosis was performed. Of the 160 patients who were examined at 1 year following surgery, 96% had some degree of facial nerve function (Fig. 4) . The data included facial function measurements in patients who underwent anastomosis proceduresJ 2 The likelihood of facial nerve preservation and the degree of facial function were found to be dependent on tumor size (Table 3) .
A uditory Nerve Function
Hearing was preserved in 52 of the 221 patients who had hearing preoperatively (Table 1) . Of the 97 patients * The facial nerve function following surgery was affected by tumor size, and occasional patients had markedly decreased or absent function at 1 year postoperatively, even when the nerve seemed anatomically preserved at surgery. Facial improvement can continue for several years following surgery so the final facial function was in some cases better than indicated above.
t Small tumors: < 2 cm; medium tumors: 2.1 to 4 cm; and large tumors ~ 4.1 cm.
with lesions 2 cm or smaller, hearing was preserved in 47 (49.5%). As expected, hearing was more commonly preserved in patients with smaller tumors (Fig. 5) ; nevertheless, we did attempt to save hearing in all patients who had hearing preoperatively. Often there was a decrease in both the pure tone average and the speech discrimination following surgery (Tables 1 and 2) , however, five patients were actually found to have improved hearing after surgery (Table 4) . We have seen delayed spontaneous return of hearing in one patient after acoustic tumor surgery, j4 Although we cannot be certain that these results will continue to improve, we do hope that the improved rate of hearing preservation in 1990 (Table 5 ) is a trend.
Complications
A summary of the complications is listed in Table 6 . The most c o m m o n complication was CSF leakage. In the 256 procedures, 28 had a CSF fistula and early repair was performed on the 24 fistulas that persisted Postoperative  normal  11  6  serviceable  28  18  poor 13 28 * Generally, hearing was the same or worse postoperatively in cases where hearing was preserved; however, in five cases heating improved. Serviceable hearing is defined as a pure tone average of 25 to 60 dB and a speech discrimination of 40% to 90%. beyond 4 days following tumor removal. The fistula was usually due to CSF entering retrolabyrinthine mastoid air cells and then draining to the ipsilateral nostril via the middle ear and eustachian tube. There was no case of wound breakdown or fluid leaking from the wound. Great success has been achieved in repairing these fistulas by drilling out the mastoid air cells and filling the middle ear and external ear canal with subcutaneous fat taken from the abdomen. 9 No patient has required CSF drainage either as a temporary adjunct to mastoid obliteration or as a permanent solution. Patients were generally kept in the hospital 4 days after such a repair.
Although no patients had a wound infection, there were two episodes of bacterial meningitis that followed persistent CSF leakage. These cases of meningitis were not found in the early postoperative period but developed following discharge from the hospital. Because of the potential for meningitis we now perform earlier operative repair of CSF leaks and we have not had any patient with meningitis after CSF leakage over the last 4 years. 1984  3  1985  8  1986  8  1987  8  1988  6  1989  4  1990 14 totalcases 52 * In 1990 we increased our effort to preserve the microvasculature that is often clustered at the inferior medial aspect of the tumor. Often an arachnoid layer will be found between these vessels and the tumor and this should be preserved if at all possible. * There were no wound infections in this group of patients, although two patients developed meningitis following a cerebrospinal fluid leak which responded to antibiotics and repair or spontaneous resolution of the leak.
t" A single patient each had one of the following problems: postoperative psychosis, neurotropic eye, facial hyperesthesia, severe headache, thrombophlebitis, cardiac arrhythmia, depression, pulmonary edema, and subdural hematoma.
Although loss of cochlear function and seventh nerve function are two of the major cranial nerve injuries that can occur during acoustic nerve surgery, there is risk of other cranial nerve injury especially in patients with larger tumors. In this series of 256 procedures, four patients had transient lower cranial nerve deficits with vocal cord paresis and swallowing difficulty. The four patients who developed lower cranial nerve dysfunction had neurofibromatosis and underwent surgical removal of tumors involving the ninth and 10th cranial nerves at the time of removal of their acoustic neurinoma. None of these patients required a tracheostomy; however, one patient required a feeding tube for a period of 1 month. These four patients also had neurinoma present in the contralateral cerebellopontine angle as well. In all cases these lower cranial nerve deficits improved. Four patients developed temporary diplopia secondary to sixth nerve palsies and these also improved. One patient stated that she had some new facial hypesthesia following surgery which cleared in several months. Two patients had superficial wound hematomas, one of which had to be drained. There were no intradural hematomas that required further surgery. One patient with a right acoustic tumor developed a left posterior temporal lobe bleed from an incidental arteriovenous malformation (AVM) that was not suspected prior to hemorrhage. This patient recovered nicely after angiography, evacuation of the clot, and resection of the AVM.
In this series, there were two early deaths secondary to fatal pulmonary embolus. Both of these occurred 4 days after otherwise uneventful surgery.
In the seven cases with residual tumor, there were three documented recurrences. Only one has had further surgery. Because CT or MR imaging may enhance fat placed in the porus, some apparent recurrences may not in fact represent tumor, and serial scans looking for tumor growth may be a reasonable precaution before surgical re-exploration is considered.
Discussion
Treatment Goals
This review of recent experience with acoustic neurinomas suggests a continual improvement in results of retrosigmoid surgery. This and other outcome data confirm the fact that there is a learning curve for this procedure. We consider that increased surgical experience has resulted in increasing expectations. At present, we believe that total tumor removal should be the goal when dealing with acoustic neurinoma. Occasionally it can become extremely difficult to remove the last remaining tumor cells from the facial nerve. Removal of these cells may result in significant facial nerve injury. The pros and cons of additional dissection must be determined for each patient. However, it is likely that the elderly patient will not develop signs of recurrence from these residual cells. In patients who have suffered tumor recurrence, the risk of re-exploration and tumor removal is not significantly different from that presented in this review. 1~2' 4' 13"17' 19' 21' 25 ' 28 
Role of Monitoring
Facial nerve monitoring during cerebellopontine angle surgery improves the facial nerve preservation rate, decreases the surgical time, and improves function in the facial nerves preserved. 7 The auditory feedback provides instant warning of facial nerve irritation and allows the surgeon to modify technique in order to decrease further seventh nerve trauma. By comparing the amplitude of the proximal compound muscle action potential with that obtained by distal stimulation of the facial nerve in the internal auditory canal, the team can predict the degree of initial facial weakness and the long-term result. Specifically, if the percentage amplitude is 90%, it is reasonable to expect very good early and late facial nerve function; if it is between 50% and 90%, significant temporary weakness may occur but an eventual very good result can be expected. If the reduction is greater than 50%, consideration might be given to performing a tarsorrhaphy before the patient leaves the operating room. In patients with an anatomically intact facial nerve but displaying a less than 50% amplitude of the proximal compound muscle action potential, varying degrees of permanent weakness can be expected.
The cochlear evoked responses require averaging and, therefore, the feedback is not as immediate as that in facial nerve monitoring; nevertheless, it is our experience as well as the findings of others '- '8'2~ that the evoked responses can be helpful. The coagulation of vessels or traction often precedes deterioration of cochlear evoked responses, suggesting a vascular insult to the cochlear nerve and/or the cochlear apparatus. '''3'27 Even though the cochlear nerve is frequently preserved and may even show very little evidence of being traumatized, intraoperative evoked auditory response mon-itoring may demonstrate a loss of wave V suggesting permanent irreversible hearing loss, while the persistence of wave V is compatible with a more optimistic prognosis. ~7 Using historical controls, we have shown that monitoring reduces the risk of hearing loss in patients with small tumors. 2~
Preservation of Hearing
This review demonstrates that 24% of these patients with preoperative hearing retain some hearing following surgery. The percentage is significantly higher in patients with small acoustic tumors. Only acoustic lesions were included in this review, but it is our experience that hearing preservation is much more frequent in patients with other benign cerebellopontine angle lesions. Radiographically, it may be impossible to be certain of the lesion histology. ~5 Because of hearing preservation rates of 60% in acoustic neurinomas under 1 cm in size, 49% in acoustic neurinoma under 2 cm in size, and additional personal data confirming rates even higher for similar sized nonacoustic porus region tumors, it is reasonable to use a labyrinth-sparing procedure in patients with good preoperative hearing and small tumors. Like Glasscock, et al., 5 we believe that tumor size alone should not exclude the patient from a hearing-conservation approach.
Recent reviews suggest that the risk of CSF leakage is decreased with more meticulous packing of the mastoid air cells around the porus or when taking tumor out of the invaded mastoid. Currently, we fill these air cells with a mixture of bone wax and bone dust obtained from the craniectomy burr holes. Following this, subcutaneous fat is compressed into these air cells and additional fat is glued in place with autologous fibrin glue. Symon and Pel127 have observed similar benefits from using bone dust to obliterate open air cells.
Facial Nerve Function
The retrosigmoid approach provides a very good opportunity to save facial nerve function. In fact, the facial nerve preservation rate in patients with all sizes of tumors ( Fig. 1) compares favorably with that of other reported surgical approaches. Since the quantitative determination of facial nerve function was made at 1 year following surgery, it is known that these results will improve as the follow-up period increases. The ability to save both cochlear and facial function seems to be improving. Because facial nerve function is determined at 1 year following surgery, this series does not include any data on facial nerve function from patients who had surgery during the last year; in fact, these patients showed improved cochlear preservation rates compared to preceding years.
Conclusions
The recent results of retrosigmoid acoustic neurinoma surgery compare very favorably with results of other treatment options. Although there is the potential for very serious complications (including death) from posterior fossa surgery, in this series of 256 procedures there were few central nervous system injuries related specifically to the surgical approach. We believe that the patient's age, medical status, the size of the tumor, and the state of the patient's preoperative heating, as well as the surgical team's previous operative experience should be considered when selecting a management strategy.
